London, United Kingdom, June 13, 2018 --(PR.com
)-- SMi Group is pleased to release the official agenda for the 4th annual Lyophilization USA Conference, which is due to take place in Iselin, New Jersey on November 15 - 16, 2018.
Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are required for current and future products. 16% of the top 100 pharmaceutical drugs and 35% of biologic drugs are lyophilized, and with more than 30% of the FDA-approved parenterals lyophilized and soon more than half of injectable drugs to require lyophilization, there’s a need for standardization and expansion of the lyophilization process in pharmaceuticals.
Participants will be discussing novel techniques and advances within lyophilization; regulatory challenges in lyophilization and how to overcome these challenges; unmet needs within and action points; recent analytical and other technologies in lyophilization; alternative freeze-drying methods beyond vial lyophilization.
• Alex Langford, Senior Associate Scientist, Pfizer
• Fabrice Schlegel, Senior Engineer, Amgen
• Rui Fang, Senior Scientist, Merck
• Sushma Kommareddy, Associate Director, Formulation Development, Takeda
• Alina Alexeenko, Professor, Purdue University
Further details at http://www.lyophilization-usa.com/prcom
Twitter - @SMIpharm & #lyousa
LinkedIn - SMi Pharma
+44 (0)20 7827 6000